礼来Eli Lilly & Co. (LLY) 2003年年度报告「NYSE」.pdf

1、2003Answers for ShareholdersEli Lilly and Company Annual Report,Notice of Annual Meeting,and Proxy StatementYEAR IN REVIEW 1 Financial Highlights 2 Letter to Shareholders 6 Innovation From the Lilly PipelineFINANCIALS 8 Review of Operations 13 Consolidated Statements of Income 15 Consolidated Balanc

2、e Sheets 22 Consolidated Statements of Cash Flows 23 Consolidated Statement of Comprehensive Income 24 Segment Information 25 Selected Quarterly Data 26 Selected Financial Data 27 Notes to Consolidated Financial Statements 43 Responsibility for Financial Statements 44 Report of Independent Auditors

3、PROXY STATEMENT 45 Notice of 2004 Annual Meeting and Proxy Statement 47 General Information 52 Board of Directors 63 Directors and Corporate Governance Committee Matters 64 Audit Committee Matters 66 Executive Compensation 72 Performance Graph 73 Ownership of Company Stock 75 Items of Business To Be

4、 Acted Upon at the Meeting 81 Other Matters 82 AppendicesCORPORATE INFORMATION 92 Senior Management 93 Corporate Information 94 Trademarks 95 Annual Meeting Admission Ticket and Parking Information12003 FINANCIAL HIGHLIGHTSEli Lilly and Company and Subsidiaries(Dollars in millions,except per-share d

5、ata)Year Ended December 31 2003 2002 Change%Net sales.$12,582.5$11,077.5 14Research and development .2,350.2 2,149.3 9Research and development as a percent of sales .18.7%19.4%Net income .$2,560.8$2,707.9(5)Earnings per sharebasic.2.38 2.51(5)Earnings per sharediluted.2.37 2.50(5)Dividends paid per

6、share.1.34 1.24 8Capital expenditures .1,706.6 1,130.9 512CHAIRMANS LETTERSidney Taurel,chairman of the board,president,and chief executive offi cer,spoke to employees worldwide via broadcast television in January 2004.Their success in overcoming the unprecedented challenges of the past couple of ye